Meihua Biotech: Algunos miembros del consejo, altos ejecutivos y la dirección central han completado compras adicionales, acumulando un 1.142% del capital total.

robot
Generación de resúmenes en curso
Meihua Biological Announcement, a total of 76 members including some directors, senior management personnel, and other core management (or technical backbone) of the company, based on confidence in the company's future development prospects and recognition of long-term investment value, plan to increase their holdings of the company's shares within 12 months starting from January 14, 2026, using their own or raised funds, with a total planned increase of no less than 304 million yuan and no more than 350 million yuan. As of June 8, 2026, the above-mentioned increase entities have cumulatively increased their holdings of 32,018,400 shares of the company through centralized bidding transactions in the secondary market, accounting for 1.142% of the company's total share capital, with a total increase amount of 316 million yuan. The increase amount has exceeded the lower limit of this increase plan, and this increase plan has been completed.
Ver original
Esta página puede contener contenido de terceros, que se proporciona únicamente con fines informativos (sin garantías ni declaraciones) y no debe considerarse como un respaldo por parte de Gate a las opiniones expresadas ni como asesoramiento financiero o profesional. Consulte el Descargo de responsabilidad para obtener más detalles.
  • Recompensa
  • Comentar
  • Republicar
  • Compartir
Comentar
Añadir un comentario
Añadir un comentario
Sin comentarios
  • Fijado